Prostate cancer Board decisions

The Veteran's service connection claims for diabetes mellitus type II, hypertension, prostate cancer, erectile dysfunction, rectal cancer, and hypothyroidism are all granted due to presumed exposure to herbicide agents during his service on the U.S.S. Preble in Vietnam.

The Veteran's testicular disability is granted as secondary to his service-connected prostate cancer, effective August 10, 2022.

The Board has determined that the RO did not substantially comply with prior remand instructions and thus, both prostate cancer and erectile dysfunction claims are being returned for further development.

The Veteran's claims for service connection for Crohn's disease, prostate cancer, erectile dysfunction secondary to prostate cancer, and type II diabetes mellitus have been granted. The claim for increased rating for hemorrhoids prior to February 16, 2012 and in excess of 20 percent thereafter is remanded.

The Veteran's prostate cancer and chronic lymphocytic leukemia were denied service connection as there was no evidence of herbicide exposure during service, and the diseases did not manifest to a compensable degree within one year of separation.

The Veteran's claim for service connection for prostate cancer is denied.,Service connection has been granted for voiding dysfunction, to include as secondary to prostate cancer.

The Board has remanded the claims for prostate and colon cancer due to exposure to asbestos and/or herbicide agents, as well as the TBI claim. The case will be returned for further development.

The Veteran's claim for an increased rating for residuals of prostate cancer was denied, and his claim for a compensable disability rating for bilateral hearing loss was also denied.

The Board has remanded the case for further development due to concerns about the competency of the VA examiners who provided the medical opinions used in assigning disability ratings and effective dates.

The Board has remanded the case due to issues with work history verification and clarification of employment status from May 2018 to August 2022. The TDIU claim is inextricably intertwined with the claims for higher ratings for PTSD and voiding dysfunction prior to August 10, 2022.

The Veteran's prostate cancer, erectile dysfunction, and incontinence are all granted service connection. The prostate cancer is presumed due to herbicide agent exposure during service. Secondary service connection is also granted for the erectile dysfunction and incontinence as they are a result of his service-connected prostate cancer.

The Veteran's prostate cancer is granted as service-connected due to exposure to toxic substances, including Agent Orange. The left shoulder strain claim remains denied.

The Veteran's claim for service connection for prostate cancer is granted due to exposure to herbicide agents during his active service. The claim for gallbladder surgery and removal is remanded as the evidence does not meet the criteria for a VA examination under the PACT Act.

The Veteran's prostate cancer is related to toxic exposures during service, and the Board has granted direct service connection for prostate cancer.

The Board denied the Veteran's claims for service connection for prostate cancer and erectile dysfunction, finding that there was no evidence of exposure to Agent Orange or other herbicides during his service in Korea. The Court vacated the decision due to insufficient consideration of submitted internet articles.

The Board denied the Veteran's claim for service connection for a prostate disorder, finding that there was no evidence of prostate cancer or any related condition during his military service and that the evidence did not support a nexus between his claimed conditions and his military service.

The Veteran's prostate cancer is etiologically related to his ionizing radiation exposure during service, and the Board has granted service connection for this condition.

The Veteran's prostate cancer residuals, manifested by voiding dysfunction requiring the wearing of absorbent materials that must be changed two to four times per day, are granted a 40 percent evaluation for the period beginning October 1, 2019. The Veteran's erectile dysfunction is denied as compensable.

The Veteran's service connection claims for hypothyroidism, ischemic heart disease, prostate cancer, diabetes mellitus, and peripheral neuropathy have been granted with initial evaluations of 30 percent each.

The Veteran's claims for earlier effective dates for prostate cancer and non-Hodgkin's lymphoma are granted, but the claim for earlier effective date for special monthly compensation is denied.